Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation

Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation

Intravitreal ranibizumab therapy is widely used in treatment of subfoveal choroidal neovascularisation (CNV) in age-related macular degeneration. We wanted to study the effect of intravitreal ranibizumab therapy in peripapillary CNV. A prospective recording of treatment outcomes in twelve eyes (12 p...

Full description

Bibliographic Details
Main Authors:	Hassan Hamoudi, Torben Lykke Sørensen
Format:	Article
Language:	English
Published:	Hindawi Limited 2011-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2011/602729

Similar Items

Successful management of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension with intravitreal ranibizumab
by: Nitin Kumar, et al.
Published: (2018-01-01)

Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma
by: Sidra Zafar, et al.
Published: (2016-12-01)

Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
by: Ellabban AA, et al.
Published: (2012-05-01)

Single intravitreal ranibizumab for myopic choroidal neovascularization
by: Shatriah I, et al.
Published: (2011-08-01)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
by: Nikunj J Shah, et al.
Published: (2011-01-01)

Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization Secondary to Endogenous Endophthalmitis
by: Shwu-Jiuan Sheu
Published: (2009-11-01)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
by: Neeraj Pandey, et al.
Published: (2013-01-01)

Treatment of choroidal neovascularisation in highly myopic eyes
by: Alenka Lavrič, et al.
Published: (2012-06-01)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
by: Karagiannis D, et al.
Published: (2017-06-01)

Long-Term Follow-Up of Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization due to Choroidal Osteoma
by: Zenith H.Y. Wu, et al.
Published: (2012-06-01)

Intravitreal conbercept for choroidal neovascularisation secondary to pathological myopia in a real‐world setting in China
by: Xin Nie, et al.
Published: (2021-03-01)

Treatment of Punctate Inner Choroidopathy with Choroidal Neovascularization Using Corticosteroid and Intravitreal Ranibizumab
by: Wei Wu, et al.
Published: (2018-01-01)

Development of gene therapy for choroidal neovascularisation
by: Balaggan, K. S.
Published: (2011)

Effect of intravitreal injection of Ranibizumab on choroid in patients with severe NPDR with macular edema
by: Fu-Qin Du, et al.
Published: (2017-11-01)

Effect of photodynamic therapy combined with intravitreal ranibizumab injection on circumscribed choroidal hemangioma
by: Yu-Shun Xue, et al.
Published: (2017-02-01)

Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)
by: Bhurayanontachai P, et al.
Published: (2011-05-01)

Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab
by: Makri OE, et al.
Published: (2018-09-01)

The effect of intravitreal administration of bevacizumab on macular edema and visual acuity in age-related macular degeneration with subfoveolar choroidal neovascularisation
by: Ristić Dragana, et al.
Published: (2013-01-01)

Efficacy of intravitreal Ranibizumab injection for choroidal neovascularization secondary to pathologic myopia
by: Li-Hong Cui, et al.
Published: (2016-03-01)

Clinical Efficacy of Intravitreal Ranibizumab in Early and Mid-Idiopathic Choroidal Neovascularization
by: Chuanfeng Fan, et al.
Published: (2014-01-01)

Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis
by: Miura M, et al.
Published: (2013-08-01)

Neuropilin 1 Involvement in Choroidal and Retinal Neovascularisation.
by: Patricia Fernández-Robredo, et al.
Published: (2017-01-01)

Matrix Metalloproteinase 10 Contributes to Choroidal Neovascularisation
by: Bezunartea, J., et al.
Published: (2022)

Dramatic response of iris and retinal neovascularisation following usage of intravitreal ranibizumab as pre-operative adjunct in vitrectomy for advanced proliferative diabetic retinopathy
by: Malisa A, et al.
Published: (2011)

Intravitreal ranibizumab for peripapillary neovascular membrane associated to papiledema due to idiopathic intracranial hypertension: a case report
by: Muñoz Cardona, Marta Lucia, et al.
Published: (2014-01-01)

Effects of three consecutive monthly intravitreal injection of ranibizumab for polypoidal choroidal vasculopathy in Korea
by: Young Gun Park, et al.
Published: (2015-04-01)

Therapeutic effect of photodynamic therapy and intravitreal injection with ranibizumab for choroidal neovascularization of pathologic myopia
by: Cong Zhang, et al.
Published: (2014-07-01)

Peripapillary Choroidal Neovascular Membrane Secondary to Sarcoidosis-Related Panuveitis: Treatment with Aflibercept and Ranibizumab with a 50-month Follow-Up
by: Artemis Matsou, et al.
Published: (2021-04-01)

Combination therapy of low-fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane in choroidal osteoma
by: Rodney J Morris, et al.
Published: (2011-01-01)

The Use of Intravitreal Ranibizumab for Choroidal Neovascularization Associated with Vogt-Koyanagi-Harada Syndrome
by: A. M. Kolomeyer, et al.
Published: (2011-01-01)

Photodynamic Therapy and Bevacizumab Combination for Polypoidal Choroidal Vasculopathy Refractory to Intravitreal Ranibizumab
by: Zeynep Alkin, et al.
Published: (2016-12-01)

Macular vortex vein with choroidal neovascularisation in pathologic myopia
by: Ike M Schouten, et al.
Published: (2019-01-01)

Intravitreal Ranibizumab in the Treatment of Butterfly-Shaped Pattern Dystrophy Associated with Choroidal Neovascularization: A Case Report
by: Theodoros Empeslidis, et al.
Published: (2012-02-01)

Acute and subacute macular and peripapillary angiographic changes in choroidal and retinal blood flow post-intravitreal injections
by: Nadhini Arumuganathan, et al.
Published: (2021-09-01)

Intravitreal Ranibizumab Therapy for Choroidal Neovascularization Secondary to Pathological Myopia: 3 Year Outcome
by: İrfan Perente, et al.
Published: (2018-04-01)

Long-term results of intravitreal ranibizumab for osteoma-related choroidal neovascularization in a child
by: Aditi Gupta, et al.
Published: (2014-01-01)

Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization
by: Petrou P, et al.
Published: (2013-10-01)

Clinical efficacy of intravitreal Ranibizumab in idiopathic choroid neovascularization type Ⅰand type Ⅱ
by: Yue-Ming Sun, et al.
Published: (2015-07-01)

Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients
by: Amin E. Nawar, et al.
Published: (2020-10-01)

Expression of purinergic receptors on microglia in the animal model of choroidal neovascularisation
by: Lu Li, et al.
Published: (2021-06-01)